Tony Walls
Overview
Explore the profile of Tony Walls including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
560
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sua T, Faatoese A, Anglemyer A, Maoate K, Walls T
N Z Med J
. 2025 Feb;
138(1609):45-55.
PMID: 39946568
Aim: To describe the epidemiology and clinical characteristics of acute rheumatic fever (ARF) cases in Canterbury, Aotearoa New Zealand, 2012-2022. Methods: Cases were identified through cross-matching public health notification data,...
2.
Berkhout A, Clark J, Jones C, Grimwood K, McMullan B, Britton P, et al.
J Antimicrob Chemother
. 2024 Nov;
80(2):354-362.
PMID: 39556200
Background: Variations in neonatal aciclovir prescribing for suspected herpes simplex virus (HSV) disease are well-known, but there are limited data describing aciclovir prescribing in older children. Methods: Medical records of...
3.
Maze M, Williman J, Anstey R, Best E, Bhally H, Bryce A, et al.
IJID Reg
. 2024 Sep;
12:100424.
PMID: 39281192
Objectives: COVID-19 severity prediction scores need further validation due to evolving COVID-19 illness. We evaluated existing COVID-19 risk prediction scores in Aotearoa New Zealand, including for Māori and Pacific peoples...
4.
Kumbaroff Z, Anglemyer A, Scott J, Duff P, Thirkell C, Walls T
Sex Transm Infect
. 2024 Aug;
100(8):538-539.
PMID: 39209540
No abstract available.
5.
Taylor A, Best E, Walls T, Webb R, Bhally H, Bryce A, et al.
IJID Reg
. 2024 Aug;
12:100408.
PMID: 39185270
Objectives: This multicenter cohort study describes Aotearoa New Zealand children hospitalized during the country's first wave of sustained SARS-CoV-2 transmission, Omicron variant. Methods: Children younger than 16 years, hospitalized for...
6.
Martin N, Williman J, Walls T, Sadarangani M, Grant C
Pediatr Infect Dis J
. 2024 May;
43(10):924-930.
PMID: 38754002
Background: Most childhood meningitis is viral in countries with widespread conjugate vaccine use. This study assessed clinical features and neurodevelopmental outcomes in preschool children following enteroviral and parechoviral meningitis. Methods:...
7.
Anglemyer A, Ren X, Gilkison C, Kumbaroff Z, Morgan J, DuBray K, et al.
Lancet Reg Health West Pac
. 2024 May;
46:101082.
PMID: 38745973
Background: In Aotearoa New Zealand (NZ) PCV7 was introduced in 2008, then PCV10 in 2011 and PCV13 in 2014. In 2017 PCV10 was re-introduced, replacing PCV13. In the present study,...
8.
Walls T, Bowen E, Elsmore A, Lucas N
Influenza Other Respir Viruses
. 2024 Feb;
18(3):e13265.
PMID: 38420686
No abstract available.
9.
Kumbaroff Z, Duff P, Saxton P, Sonder G, Thirkell C, Scott J, et al.
Sex Transm Dis
. 2023 Oct;
50(12):775-781.
PMID: 37824285
Background: Chlamydia, gonorrhea, and syphilis are common sexually transmitted infections that disproportionately affect specific groups in New Zealand (NZ). Predictors of reinfection are not well studied in NZ but could...
10.
Hagedoorn N, Anglemyer A, Gilkison C, Hartley M, Walls T
Lancet Reg Health West Pac
. 2023 Aug;
36:100764.
PMID: 37547043
Background: The Australian immunisation schedule uses 13-valent pneumococcal conjugate vaccine (PCV13), while New Zealand (NZ) changed from PCV13 to 10-valent PCV (PCV10) in 2017. In NZ, cases of serotype 19A...